“This preclinical demonstration that stent deployment of microcrystalline drug in combination with a rapidly absorbable polymer, such as with MiStent, results in more uniform drug dosing that could lead to more rapid and uniform healing across the treated segment,” said David Kandzari, M.D., Director of Interventional Cardiology and Chief Scientific Officer, Piedmont […]
Author: Ken Dropiewski
PQ Bypass Announces First Patient Treated in Landmark DETOUR II Trial Evaluating New Treatment Approach for Clogged Leg Arteries
SUNNYVALE, Calif.–(BUSINESS WIRE)– PQ Bypass, a clinical-stage medical technology company that has developed the DETOUR procedure, a novel treatment for long (>15 cm) superficial femoral artery (SFA) blockages, announced enrollment of the first patients in the pivotal DETOUR II Trial in the United States. The trial is a prospective, single-arm clinical […]
Corindus Receives FDA Clearance for CorPath® GRX System in Peripheral Vascular Interventions
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American:CVRS), a leading developer of precision vascular robotics, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of its CorPath GRX System in peripheral vascular interventions. The CorPath System is the first and only FDA-cleared […]
Cardiva Medical Brings Total Financing Round to $41 Million; Announces Sponsorship of AMBULATE Trial, First Vascular Closure Trial Targeted at High Growth Electrophysiology Procedures
New Vascular Closure Device for Multi-Access Mid-Bore Vein Procedures, Specifically Cardiac Ablation, Aims to Reduce Time to Ambulation and Improve the Patient Experience SANTA CLARA, Calif.–(BUSINESS WIRE)– Cardiva Medical ®, an innovator in the field of vascular closure, today announced that the company has closed on $11 million in additional financing – […]
Cook Medical Realigns One-Third of Its Global Workforce to Better Support Customers, Enable Future Growth and Provide Opportunity for Employees
BLOOMINGTON, Ind.–(BUSINESS WIRE)– Today, Cook Medical announced key changes that simplify its organizational structure to better support customers. These changes realign the current sales, marketing, research and development, and customer service teams in addition to establishing new distribution channel management and medical education teams. The changes are a direct result of feedback […]
Catheter Precision Launches Clinical Trial for Its VIVO™ Non-Invasive Mapping System
Study Expected to Expand to Five Hospitals and Evaluate Accuracy of the VIVO System LEDGEWOOD, N.J., Feb. 20, 2018 /PRNewswire/ — Catheter Precision, Inc.. announces the initiation of a pivotal clinical trial to assess the accuracy and safety of the VIVO™ (View Into Ventricular Onset) Non-Invasive Mapping System. The VIVO system […]
Mitralign raises $10m
Mitralign raises $10m FEBRUARY 21, 2018 BY BRAD PERRIELLO, MassDevice Mitralign, which is looking to commercialize its namesake mitral valve treatment and pursue regulatory nods for its Trialign tricuspid valve device, said it raised nearly $10 million. The $9.8 million funding, of a hoped-for $30.2 million, came from 19 unnamed investors beginning […]
CRM Devices Market Size Worth $32.4 Billion By 2025 | CAGR: 7.8%: Grand View Research, Inc.
SAN FRANCISCO, February 19, 2018 /PRNewswire/ — The global cardiac rhythm management (CRM) devices market size is anticipated to reach USD 32.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR during the forecast period. Increase in demand for CRM devices can be attributed to supportive legislative policies […]
Osprey Study Chosen for “Best of Best” Presentation at Society for Cardiovascular Angiography and Interventions Conference
MINNESOTA, United States–(BUSINESS WIRE)– Osprey Medical Inc.(ASX:OSP) today announced a multi-center observational study for the DyeVert Plus™ System will feature at the Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Session in April 2018. The abstract entitled: A Multi-Center Observational Study of the DyeVert Plus™ Contrast Reduction System summarizes a single-arm, multi-center observational […]
Cardiac Insight, Inc. Welcomes Renowned Atrial Fibrillation Cardiologists Professor John Camm and Albert L. Waldo, MD to its Scientific Advisory Board
KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable medical devices and diagnostic software, announced today the company continues to garner global interest in its approach to cardiac care, and has added renowned cardiologists and atrial fibrillation (AFib) specialists, Professor John Camm and Albert L. Waldo, MD, PhD […]
Recent
UBC MOSAIC and LifeLabs Unlock New Ways to Manage and Predict Heart Health
Ruixiang Silicone Releases Platinum-Cured Medical Silicone Tubing for Cardiac, Infusion, and Hemodialysis Device Manufacturers
AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions
Popular
- No commented posts yet